Multiplex Assay Kit for Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) ,etc. by FLIA (Flow Luminescence Immunoassay)

G3PD; GAPD; Peptidyl-cysteine S-nitrosylase GAPDH

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 82-103 85
EDTA plasma(n=5) 89-96 92
heparin plasma(n=5) 92-105 96
sodium citrate plasma(n=5) 90-97 94

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 79-94% 96-104% 82-93% 96-103%
EDTA plasma(n=5) 92-101% 80-89% 94-102% 80-101%
heparin plasma(n=5) 80-101% 96-104% 88-101% 92-101%
sodium citrate plasma(n=5) 81-96% 89-103% 79-104% 88-95%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:GAPDH) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Clin Cancer Res Inactivation of the p53–KLF4–CEBPA Axis in Acute Myeloid Leukemia PubMed: 26408402
Clin Cancer Res Inactivation of the p53–KLF10–CEBPA Axis in Acute Myeloid Leukemia PubMed: 26408402
Diabetes & Metabolism Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells. pubmed:28499695
Scientific Reports Adhesion of Toxoplasma gondii tachyzoite-infected vehicle leukocytes to capillary endothelial cells triggers timely parasite egression pubmed:28720868
Journal of Biological Chemistry Biochemical characterization of the PHARC associated serine hydrolase ABHD12 reveals its preference for very long chain lipids Pubmed: 30237167
Biomaterials Untangling the response of bone tumor cells and bone forming cells to matrix stiffness and adhesion ligand density by means of hydrogels Pubmed: 30343256
Bulletin of Experimental Biology and Medicine Influence of Magnetite Nanoparticles and Quantum Dots on the Expression of Reference Genes in Peripheral Blood Cells Pubmed: 30488202
Journal of Medicinal Chemistry Discovery, Optimization and Target Identification of Novel Potent Broad-Spectrum Antiviral Inhibitors Pubmed: 30938999
International Immunopharmacology Methionine enkephalin (MENK) regulates the immune pathogenesis of type 2 diabetes mellitus via the IL-33/ST2 pathway Pubmed: 31078923
Cancers Rationale for a Combination Therapy Consisting of MCL1-and MEK-Inhibitors in Acute Myeloid Leukemia Pubmed: 31718075
Biological research Linc-OIP5 in the breast cancer cells regulates angiogenesis of human umbilical vein endothelial cells through YAP1/Notch/NRP1 signaling circuit at a tumor … Pubmed: 32046779
Biomed Pharmacother Silence of FAM83H-AS1 promotes chemosensitivity of gastric cancer through Wnt/β-catenin signaling pathway Pubmed: 32028241
Metab Brain Dis Ginger and turmeric lipid-solubles attenuate heated oil-induced oxidative stress in the brain via the upregulation of NRF2 and improve cognitive function in rats Pubmed: 33170419
South African Journal of Botany Evaluation of the effect of herbal extracts and their bioactive compounds against motion sickness by regulating neurotransmitter levels in vitro and in vivo
Regulation of hepatic lipid metabolism in CB1-/-and Abcb4-/--HBV surface protein transgenic mice
Cancers (Basel) BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia. Cancers 2021, 13, 581 33540760
MOLECULAR CANCER RESEARCH Omega-3 Eicosapentaenoic Acid Reduces Prostate Tumor Vascularity 33262291
Sci Rep Curcumin derivative ST09 modulates the miR-199a-5p/DDR1 axis and regulates proliferation and migration in ovarian cancer cells 34837026
Cancer Rep (Hoboken) Curcumin alters distinct molecular pathways in breast cancer subtypes revealed by integrated miRNA/mRNA expression analysis Pubmed:34981672
Prog Neurobiol Retinoic acid receptor beta protects striatopallidal medium spiny neurons from mitochondrial dysfunction and neurodegeneration Pubmed:35151792
Plant Molecular Biology Arabidopsis GELP7 functions as a plasma membrane-localized acetyl xylan esterase, and its overexpression improves saccharification efficiency Pubmed:35577991
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB932Hu02 Recombinant Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Positive Control; Immunogen; SDS-PAGE; WB.
RPB932Hu03 Recombinant Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Positive Control; Immunogen; SDS-PAGE; WB.
RPB932Hu01 Recombinant Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Positive Control; Immunogen; SDS-PAGE; WB.
PAB932Hu01 Polyclonal Antibody to Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) WB; IHC; ICC; IP.
CAB932Hu01 Anti-Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Polyclonal Antibody Loading Control of WB.
PAB932Hu02 Polyclonal Antibody to Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) WB; IHC; ICC; IP; FCM
LAB932Hu71 Biotin-Linked Polyclonal Antibody to Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) WB; IHC; ICC.
MAB932Hu24 Monoclonal Antibody to Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) WB; IHC; ICC; IP.
MAB932Hu25 Monoclonal Antibody to Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) WB; IHC; ICC; IP.
MAB932Hu27 Monoclonal Antibody to Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) WB; IHC; ICC; IP.
MAB932Hu29 Monoclonal Antibody to Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) WB; IHC; ICC; IP.
MAB932Hu22 Monoclonal Antibody to Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) WB; IHC; ICC; IP.
MAB932Hu26 Monoclonal Antibody to Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) WB; IHC; ICC; IP.
MAB932Hu28 Monoclonal Antibody to Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) WB; IHC; ICC; IP.
CAB932Hu22 Anti-Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Monoclonal Antibody Loading Control of WB;IHC;IF
MAB932Hu21 Monoclonal Antibody to Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) WB; IHC; ICC; IP.
MAB932Hu23 Monoclonal Antibody to Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) WB; IHC; ICC; IP.
SEB932Hu ELISA Kit for Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Enzyme-linked immunosorbent assay for Antigen Detection.
SCB932Hu CLIA Kit for Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Chemiluminescent immunoassay for Antigen Detection.
LMB932Hu Multiplex Assay Kit for Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.